Impact of Nirsevimab on Pediatric RSV-Related Lower Respiratory Tract Infections: A Retrospective Pre-Post Observational Study in Tuscany, Italy. [PDF]
Nieddu F +14 more
europepmc +1 more source
Impact of Nirsevimab on bronchiolities in pediatric primary care in Lazio Region: an observational study. [PDF]
Petrone D +8 more
europepmc +1 more source
Nirsevimab effectiveness, number needed to immunize and impact on severe RSV outcomes, a test-negative study in Quebec, Canada. [PDF]
Carazo S +9 more
europepmc +1 more source
Estimation of Public Health Impact with Use of Nirsevimab During the 2024-2025 RSV Season in the USA: a Modeling Study. [PDF]
Yarnoff B +11 more
europepmc +1 more source
Nirsevimab in High-Risk Infants in a Respiratory Syncytial Virus Prevention Strategy.
Sauré D +10 more
europepmc +1 more source
Impact of Nirsevimab on Respiratory Syncytial Virus PCR Test Positivity in Young Infants: A Community-Level Observational Study in Queensland, Australia. [PDF]
El-Heneidy A +6 more
europepmc +1 more source
Bivalent RSV prefusion F vaccination elicits effective neutralization of contemporary and monoclonal antibody-resistant RSV strains. [PDF]
Chen W +14 more
europepmc +1 more source
In response to the article «Reluctance of parents to immunize their children with nirsevimab»
David, Andina Martínez +3 more
openaire +2 more sources

